Open to all Yale affiliates, this program is designed to give an introduction to the field of biotechnology investment and acquire the knowledge of how to break into the industry.

Yale Biotech Club 2026 Bioinvestment & VC Series

Learn how IP shapes biotech commercialization pathways & strategic IP partnerships.

Session 3: Biotech’s Strategic Engine: Intellectual Property & Transactions.         David Lewin, PhD; President, Life Science, Latent Alpha

Mirabel Solomon

Stacy Li

Deb Simkin, MD

Qiao Li

Yanyu Zhao

Fatemeh Asghari

Clara Abraham

Ryder Lariviere

lengxi huang

Rui Ruan

degular

Ran Liu

Sara Ahmed

Standard